“Safety and Tolerability of Fixed Combination Halobetasol Propionate 0.01% and Tazarotene 0.045% (HP/TAZ) Lotion in Patients With Moderate-to-Severe Plaque Psoriasis: Results From a 1-Year, Open-Label Study” (2020) SKIN The Journal of Cutaneous Medicine, 4(5), p. s38. doi:10.25251/skin.4.supp.38.